[HTML][HTML] The Role of SMAD4 Inactivation in Epithelial–Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link?
ML Racu, L Lebrun, AA Schiavo, C Van Campenhout… - Cancers, 2022 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is currently one of the
deadliest cancers. Despite the progress that has been made in the research of patient care …
deadliest cancers. Despite the progress that has been made in the research of patient care …
The Role of SMAD4 Inactivation in Epithelial-Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link?
ML Racu, L Lebrun, AA Schiavo, C Van Campenhout… - Cancers, 2022 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) presents a five-year survival rate of 10% and its
incidence increases over the years. It is, therefore, essential to improve our understanding of …
incidence increases over the years. It is, therefore, essential to improve our understanding of …
[引用][C] The Role of SMAD4 Inactivation in Epithelial-Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link?
ML Racu, L Lebrun, AA Schiavo… - Cancers …, 2022 - difusion.ulb.ac.be
The Role of SMAD4 Inactivation in Epithelial-Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link?
ML Racu, L Lebrun, AA Schiavo… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) presents a five-year survival rate of 10% and its
incidence increases over the years. It is, therefore, essential to improve our understanding of …
incidence increases over the years. It is, therefore, essential to improve our understanding of …
The Role of SMAD4 Inactivation in Epithelial–Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link?
ML Racu, L Lebrun, AA Schiavo, C Van Campenhout… - Cancers, 2022 - cir.nii.ac.jp
抄録< jats: p> Pancreatic ductal adenocarcinoma (PDAC) presents a five-year survival rate
of 10% and its incidence increases over the years. It is, therefore, essential to improve our …
of 10% and its incidence increases over the years. It is, therefore, essential to improve our …
The Role of SMAD4 Inactivation in Epithelial–Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link?
ML Racu, L Lebrun, AA Schiavo… - …, 2022 - search.ebscohost.com
Abstract Simple Summary: Pancreatic ductal adenocarcinoma (PDAC) is currently one of the
deadliest cancers. Despite the progress that has been made in the research of patient care …
deadliest cancers. Despite the progress that has been made in the research of patient care …
[HTML][HTML] The Role of SMAD4 Inactivation in Epithelial–Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link?
ML Racu, L Lebrun, AA Schiavo, C Van Campenhout… - Cancers, 2022 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) presents a five-year survival rate of 10% and its
incidence increases over the years. It is, therefore, essential to improve our understanding of …
incidence increases over the years. It is, therefore, essential to improve our understanding of …
The Role of SMAD4 Inactivation in Epithelial–Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link?
ML Racu, L Lebrun, AA Schiavo… - …, 2022 - search.proquest.com
Pancreatic ductal adenocarcinoma (PDAC) presents a five-year survival rate of 10% and its
incidence increases over the years. It is, therefore, essential to improve our understanding of …
incidence increases over the years. It is, therefore, essential to improve our understanding of …
The Role of SMAD4 Inactivation in Epithelial-Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link?
ML Racu, L Lebrun, AA Schiavo, C Van Campenhout… - Cancers, 2022 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) presents a five-year survival rate of 10% and its
incidence increases over the years. It is, therefore, essential to improve our understanding of …
incidence increases over the years. It is, therefore, essential to improve our understanding of …